Stock market Updates | Glaxosmithkline Pharmaceuticals Ltd. | R Wadiwala Securities Pvt Ltd

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2170.5523.4 (+1.09 %)
PREV CLOSE (Rs.) 2147.15
OPEN PRICE (Rs.) 2145.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 992
TODAY'S LOW / HIGH (Rs.)2142.10 2179.10
52 WK LOW / HIGH (Rs.)1228 2649.95
NSE2173.1526.05 (+1.21 %)
PREV CLOSE( Rs. ) 2147.10
OPEN PRICE (Rs.) 2147.10
BID PRICE (QTY) 2173.15 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5670
TODAY'S LOW / HIGH(Rs.) 2144.30 2184.00
52 WK LOW / HIGH (Rs.)1227 2524

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
Stock Summary
Trade Value (Rs. in Lacs)
21.48
Dividend Yield(%)
1.47
TTM EPS (Rs.)
30.88
P/E Ratio
70.29
Book Value (Rs.)
94.04
Face Value (Rs.)
10
MCap (Rs. in Mn)
367704.27
Price/Earning (TTM)
62.13
Price/Sales (TTM)
11.22
Price/Book (MRQ)
23.08
PAT Margin (%)
17.12
ROCE (%)
37.66
company info
Incorporation Year : 13-11 1924

Management Info :

R S Karnad - Chairman Bhushan Akshikar - Managing Director

Registered Office :

Address : Gsk House, Dr. Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone : 022-24959595

Website : www.gsk-india.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
News
27Feb Glaxosmithkline Pharmaceuticals inform
Pursuant to Regulation 39 and other application regulations of SEBI (Lis..
23Feb GlaxoSmithKline Pharmaceuticals inform
Pursuant to Regulation 39 and other application regulations of SEBI (Lis..
21Feb Glaxosmithkline Pharmaceuticals inform
Glaxosmithkline Pharmaceuticals has informed that pursuant to Regulation..
Financials
QTR Dec 23 ANNUAL 23
Net Profit454.9000000000016077.5
Gross Profit 651.100000000001 8323.8
Operating Profit 2458.5 9009.3
Net Sales 8049.8 32163.4
Rs. in Millions
Rolling Forward P/E (EOD)
Event Calendar
peer group
Sanofi India (BSE)
Rwadiwala-peer-arrow  8736.10 (0.77%)
M.Cap (Rs. in Cr)20119.78
Aurobindo Pharma (BSE)
Rwadiwala-peer-arrow  1076.10 (4.83%)
M.Cap (Rs. in Cr)63052.85
Dr. Reddy's Lab (BSE)
Rwadiwala-peer-arrow  6241.00 (0.70%)
M.Cap (Rs. in Cr)104108.09
RPG Life Sciences (BSE)
Rwadiwala-peer-arrow  1560.05 (2.21%)
M.Cap (Rs. in Cr)2580.17
Shareholding Pattern
PROMOTERS
75%
MUTUAL FUNDS/UTI
4.5%
FI/BANKS/INSURANCE
4.04%
NON-INSTITUTION
13.43%
GOVERNMENT
0.01%
FII
0%